UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Signaling Pathways in Melanogenesis

International Journal of Molecular Sciences, 2016-07, Vol.17 (7), p.1144-1144

2016

Volltextzugriff (PDF)

Emerging role of long non-coding RNA SOX2OT in SOX2 regulation in breast cancer

PloS one, 2014-07, Vol.9 (7), p.e102140-e102140

2014

Volltextzugriff (PDF)

DNA-Binding Anticancer Drugs: One Target, Two Actions

Molecules (Basel, Switzerland), 2021-01, Vol.26 (3), p.552

2021

Volltextzugriff (PDF)

Multiple Drug Resistance Mechanisms in Cancer

Molecular biotechnology, 2010-11, Vol.46 (3), p.308-316

Baguley, Bruce C

2010

Volltextzugriff (PDF)

Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma

Cancer discovery, 2014-12, Vol.4 (12), p.1418-1429

2014

Volltextzugriff (PDF)

Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer

BMC cancer, 2020-05, Vol.20 (1), p.470-470, Article 470

2020

Volltextzugriff (PDF)

Diverse mechanisms activate the PI 3-kinase/mTOR pathway in melanomas: implications for the use of PI 3-kinase inhibitors to overcome resistance to inhibitors of BRAF and MEK

BMC cancer, 2021-02, Vol.21 (1), p.136-136, Article 136

2021

Volltextzugriff (PDF)

A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types

Biochemical journal, 2011-08, Vol.438 (1), p.53-62

2011

Volltextzugriff (PDF)

Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines

PloS one, 2015-07, Vol.10 (7), p.e0131400-e0131400

2015

Volltextzugriff (PDF)

Comparison of Global DNA Methylation Patterns in Human Melanoma Tissues and Their Derivative Cell Lines

Cancers, 2021-04, Vol.13 (9), p.2123

2021

Volltextzugriff (PDF)

A gene expression signature of invasive potential in metastatic melanoma cells

PloS one, 2009-12, Vol.4 (12), p.e8461-e8461

2009

Volltextzugriff (PDF)

Inhibitors of pan-PI3K Signaling Synergize with BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth

Frontiers in oncology, 2015-06, Vol.5, p.135-135

2015

Volltextzugriff (PDF)

Comparison of the effects of the PI3K/mTOR inhibitors NVP-BEZ235 and GSK2126458 on tamoxifen-resistant breast cancer cells

Cancer biology & therapy, 2011-06, Vol.11 (11), p.938-946

2011

Volltextzugriff (PDF)

Relationships between signaling pathway usage and sensitivity to a pathway inhibitor: examination of trametinib responses in cultured breast cancer lines

PloS one, 2014-08, Vol.9 (8), p.e105792

2014

Volltextzugriff (PDF)

Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers

Frontiers in oncology, 2017-09, Vol.7, p.184-184

2017

Volltextzugriff (PDF)

The paradox of cancer cell apoptosis

Frontiers in bioscience, 2011-01, Vol.16 (5), p.1759-1767

Baguley, Bruce C

2011

Volltextzugriff (PDF)

Review of high-dose intravenous vitamin C as an anticancer agent

Asia-Pacific journal of clinical oncology, 2014-03, Vol.10 (1), p.22-37

2014

Volltextzugriff (PDF)

Epigenetic regulation in human melanoma: past and future

Epigenetics, 2015-02, Vol.10 (2), p.103-121

2015

Volltextzugriff (PDF)

Multiseed liposomal drug delivery system using micelle gradient as driving force to improve amphiphilic drug retention and its anti-tumor efficacy

Drug delivery, 2018, Vol.25 (1), p.611-622

2018

Volltextzugriff (PDF)

Retrotransposon hypomethylation in melanoma and expression of a placenta-specific gene

PloS one, 2014-04, Vol.9 (4), p.e95840-e95840

2014

Volltextzugriff (PDF)

Correction: Sarkar, D., et al. Multiple Isoforms of ANRIL in Melanoma Cells: Structural Complexity Suggests Variations in Processing. Int. J. Mol. Sci. 2017, 18 , 1378

International journal of molecular sciences, 2018-05, Vol.19 (5), p.1343

2018

Volltextzugriff (PDF)

Derivation of Breast Cancer Cell Lines Under Physiological (5%) Oxygen Concentrations

Frontiers in oncology, 2018-10, Vol.8, p.425-425

2018

Volltextzugriff (PDF)

MCF-7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin sensitivity

Cancer biology & therapy, 2010-05, Vol.9 (9), p.717-724

2010

Volltextzugriff (PDF)

Disrupting tumour blood vessels

Nature reviews. Cancer, 2005-06, Vol.5 (6), p.423-435

2005

Volltextzugriff (PDF)

5,6-Dimethylxanthenone-4-Acetic Acid in the Treatment of Refractory Tumors: a Phase I Safety Study of a Vascular Disrupting Agent

Clinical cancer research, 2006-03, Vol.12 (6), p.1776-1784

2006

Volltextzugriff (PDF)

1 – 25 von 429

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(353)
Mit Volltextzugriff
(351)

Publikationsform

Artikel
(400)
Buchkapitel
(28)
Bücher
(1)

Sprache

Englisch
(429)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(278)
Life Sciences & Biomedicine
(272)
Animals
(208)
Mice
(161)
Biological And Medical Sciences
(159)
Humans
(155)
Oncology
(155)
Medical Sciences
(154)
Pharmacology. Drug Treatments
(143)
Antineoplastic Agents
(132)
Pharmacology & Pharmacy
(117)
Antineoplastic Agents - Pharmacology
(104)
Structure-Activity Relationship
(75)
Chemotherapy
(71)
General Aspects
(61)
Chemistry
(56)
Antineoplastic Agents - Therapeutic Use
(55)
Chemistry, Medicinal
(55)
Female
(55)
Biochemistry & Molecular Biology
(53)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Signaling Pathways in Melanogenesis

Emerging role of long non-coding RNA SOX2OT in SOX2 regulation in breast cancer

DNA-Binding Anticancer Drugs: One Target, Two Actions

Multiple Drug Resistance Mechanisms in Cancer

Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma

Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer

Diverse mechanisms activate the PI 3-kinase/mTOR pathway in melanomas: implications for the use of PI 3-kinase inhibitors to overcome resistance to inhibitors of BRAF and MEK

A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types

Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines

Comparison of Global DNA Methylation Patterns in Human Melanoma Tissues and Their Derivative Cell Lines

A gene expression signature of invasive potential in metastatic melanoma cells

Inhibitors of pan-PI3K Signaling Synergize with BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth

Comparison of the effects of the PI3K/mTOR inhibitors NVP-BEZ235 and GSK2126458 on tamoxifen-resistant breast cancer cells

Relationships between signaling pathway usage and sensitivity to a pathway inhibitor: examination of trametinib responses in cultured breast cancer lines

Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers

The paradox of cancer cell apoptosis

Review of high-dose intravenous vitamin C as an anticancer agent

Epigenetic regulation in human melanoma: past and future

Multiseed liposomal drug delivery system using micelle gradient as driving force to improve amphiphilic drug retention and its anti-tumor efficacy

Retrotransposon hypomethylation in melanoma and expression of a placenta-specific gene

Correction: Sarkar, D., et al. Multiple Isoforms of ANRIL in Melanoma Cells: Structural Complexity Suggests Variations in Processing. Int. J. Mol. Sci. 2017, 18 , 1378

Derivation of Breast Cancer Cell Lines Under Physiological (5%) Oxygen Concentrations

MCF-7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin sensitivity

Disrupting tumour blood vessels

5,6-Dimethylxanthenone-4-Acetic Acid in the Treatment of Refractory Tumors: a Phase I Safety Study of a Vascular Disrupting Agent

Suchergebnisse filtern